APA

Salvati E., Scarsella M., Porru M., Rizzo A., Iachettini S., Tentori L., Graziani G., D'Incalci M., Stevens M. F. G., Orlandi A., Passeri D., Gilson E., Zupi G., Leonetti C. & Biroccio A. (20101228). PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy. : Oncogene.

Chicago

Salvati E, Scarsella M, Porru M, Rizzo A, Iachettini S, Tentori L, Graziani G, D'Incalci M, Stevens M F G, Orlandi A, Passeri D, Gilson E, Zupi G, Leonetti C and Biroccio A. 20101228. PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy. : Oncogene.

Harvard

Salvati E., Scarsella M., Porru M., Rizzo A., Iachettini S., Tentori L., Graziani G., D'Incalci M., Stevens M. F. G., Orlandi A., Passeri D., Gilson E., Zupi G., Leonetti C. and Biroccio A. (20101228). PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy. : Oncogene.

MLA

Salvati E, Scarsella M, Porru M, Rizzo A, Iachettini S, Tentori L, Graziani G, D'Incalci M, Stevens M F G, Orlandi A, Passeri D, Gilson E, Zupi G, Leonetti C and Biroccio A. PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy. : Oncogene. 20101228.